Literature DB >> 25458834

A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.

Masamichi Nagae1, Kana Morita-Matsumoto1, Masaki Kato1, Mika Kato Kaneko2, Yukinari Kato2, Yoshiki Yamaguchi3.   

Abstract

Podoplanin is a transmembrane O-glycoprotein that binds to C-type lectin-like receptor 2 (CLEC-2). The O-glycan-dependent interaction seems to play crucial roles in various biological processes, such as platelet aggregation. Rhodocytin, a snake venom, also binds to CLEC-2 and aggregates platelets in a glycan-independent manner. To elucidate the structural basis of the glycan-dependent and independent interactions, we performed comparative crystallographic studies of podoplanin and rhodocytin in complex with CLEC-2. Both podoplanin and rhodocytin bind to the noncanonical "side" face of CLEC-2. There is a common interaction mode between consecutive acidic residues on the ligands and the same arginine residues on CLEC-2. Other interactions are ligand-specific. Carboxyl groups from the sialic acid residue on podoplanin and from the C terminus of the rhodocytin α subunit interact differently at this "second" binding site on CLEC-2. The unique and versatile binding modes open a way to understand the functional consequences of CLEC-2-ligand interactions.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25458834     DOI: 10.1016/j.str.2014.09.009

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  30 in total

1.  Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.

Authors:  Nagaharu Tsukiji; Makoto Osada; Tomoyuki Sasaki; Toshiaki Shirai; Kaneo Satoh; Osamu Inoue; Norihiko Umetani; Chihiro Mochizuki; Tamio Saito; Soichi Kojima; Hideyuki Shinmori; Yukio Ozaki; Katsue Suzuki-Inoue
Journal:  Blood Adv       Date:  2018-09-11

Review 2.  Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.

Authors:  Katsue Suzuki-Inoue
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILRα immune cell receptor.

Authors:  Atsushi Furukawa; Kosuke Kakita; Tomoki Yamada; Mikihiro Ishizuka; Jiro Sakamoto; Nanao Hatori; Naoyoshi Maeda; Fumina Ohsaka; Takashi Saitoh; Takao Nomura; Kimiko Kuroki; Hisanori Nambu; Hisashi Arase; Shigeki Matsunaga; Masahiro Anada; Toyoyuki Ose; Shunichi Hashimoto; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

4.  A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155.

Authors:  Bushra Husain; Sree R Ramani; Eugene Chiang; Isabelle Lehoux; Sairupa Paduchuri; Tia A Arena; Ashka Patel; Blair Wilson; Pamela Chan; Yvonne Franke; Athena W Wong; Jennie R Lill; Shannon J Turley; Lino C Gonzalez; Jane L Grogan; Nadia Martinez-Martin
Journal:  Mol Cell Proteomics       Date:  2019-07-15       Impact factor: 5.911

5.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

Review 6.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

7.  Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.

Authors:  Shin-Ichi Nakakita; Aiko Itoh; Yukari Nakakita; Yasuhiro Nonaka; Takashi Ogawa; Takanori Nakamura; Nozomu Nishi
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

Review 8.  Emerging roles of podoplanin in vascular development and homeostasis.

Authors:  Yanfang Pan; Lijun Xia
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

9.  Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.

Authors:  Hiroharu Oki; Satoshi Ogasawara; Mika Kato Kaneko; Michiaki Takagi; Masanori Yamauchi; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-02

10.  Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.

Authors:  Takaya Sekiguchi; Ai Takemoto; Satoshi Takagi; Kazuki Takatori; Shigeo Sato; Miho Takami; Naoya Fujita
Journal:  Oncotarget       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.